دورية أكاديمية
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
| العنوان: | Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma |
|---|---|
| المؤلفون: | Chuma, MakotoAff1, IDs12072024106808_cor1, Uojima, Haruki, Toyoda, Hidenori, Hiraoka, Atsushi, Arase, Yoshitake, Atsukawa, Masanori, Itokawa, Norio, Okubo, Tomomi, Tada, Toshifumi, Numata, Kazushi, Morimoto, Manabu, Sugimori, Makoto, Nozaki, Akito, Iwasaki, Shuichiro, Yasuda, Satoshi, Koshiyama, Yuichi, Mishima, Yusuke, Tsuruya, Kota, Tokoro, Chikako, Miura, Yuki, Hidaka, Hisashi, Kumada, TakashiAff3, Aff12, Kusano, Chika, Kagawa, Tatehiro, Maeda, Shin |
| المصدر: | Hepatology International. :1-14 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 19360533 19360541 |
|---|---|
| DOI: | 10.1007/s12072-024-10680-8 |